Eads & Heald Investment Counsel/ »

Regeneron Pharmaceuticals shares owned by Eads & Heald Investment Counsel/

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Eads & Heald Investment Counsel/ from 13F filings

Historical chart of Eads & Heald Investment Counsel/ investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Eads & Heald Investment Counsel/ consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Eads & Heald Investment Counsel/

Quarter filed Position value Share count Share price at filing
2026-06-30 $215k 345 623.54

More positions owned by Eads & Heald Investment Counsel/

NVIDIA Corporation (NVDA)
Lam Research (LRCX)
Advanced Micro Devices (AMD)
Amphenol Corporation (APH)
Caterpillar (CAT)
Apple (AAPL)
Wal-Mart Stores (WMT)
Analog Devices (ADI)
JPMorgan Chase & Co. (JPM)
W.W. Grainger (GWW)
Amazon (AMZN)
Alphabet Inc Class A cs (GOOGL)
Costco Wholesale Corporation (COST)
Broadcom (AVGO)
American Express Company (AXP)

View all positions for Eads & Heald Investment Counsel/

Top funds holding Regeneron Pharmaceuticals

BlackRock
Vanguard Capital Management
Dodge & Cox
State Street Corporation
Invesco
Jpmorgan Chase & Co
Vanguard Portfolio Management
Franklin Resources
Geode Capital Management
T. Rowe Price Associates
Nuveen
Loomis, Sayles and
Capital World Investors
Goldman Sachs Group
Morgan Stanley

View all funds holding Regeneron Pharmaceuticals